Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

30 Oct 2007 10:02

ViaLogy PLC30 October 2007 30 October 2007 ViaLogy plc AGM statement At the Annual General Meeting of ViaLogy PLC (VIY), the AIM-quoted technologycompany that is a leading innovator of network-centric, real time signalprocessing platforms for sensor applications, to be held at 10am today, theChairman, Terry Bond, will make the following statement. "It has been a year since shareholders approved the acquisition of the remainderof ViaLogy's share capital and the change of name to ViaLogy plc. During theyear the company has achieved a number of significant technical and productmilestones and the transition from research and development-driven activities tothe commercialisation of the technology is well underway. Over the next year ViaLogy will roll-out several products, principally SPM,MicroSPM and MPEX, initially targeting the defence, oil & gas and enterprisemarkets. These applications are based on ViaLogy's proprietary,patent-protected Quantum Resonance Interferometry (QRI) signal processingtechnology that enables the detection and interpretation of very weak signalsfrom large amounts of information and background noise. Ultimately SPM providesa solution to the problem of sensor integration. SPM, Sensor Policy Manager, is an enterprise-grade software product for sensorprocessing and interoperability. Unlike other sensor management solutions thatwork only with sensors from a single vendor, ViaLogy SPM software automaticallydiscovers network-attached sensors from any vendor, fuses and normalises theirinputs for central monitoring, and invokes real-time actions based oncustomer-defined policies. The network-centric approach provides measurablebenefits for security, safety and surveillance. The technology can integrate upto thousands of sensors connected to wireless and wired networks without delaysor loss of coverage. One of the early adopters of the SPM technology was Cisco Systems, which hasimplemented the technology at its San Jose campus to support safety and securityoperations, enabling the automation of complex facility operations. ViaLogy hasalso negotiated contracts for further SPM installations in the US and Taiwan. MicroSPM, is a compact, hardware-based solutions for real-time video and sensordata processing. It is designed to automate and improve the speed andeffectiveness of security and surveillance activities, such as face recognitionin crowds; human, object and vehicle detection and counting; and license platereading, in particular under difficult environment conditions. Reducingreliance on multiple human operators for analysis and decision-making. MPEX (Multi Parallax Exploitation) Electronic Eye, is a major advancement incomputer vision and video surveillance technology. In development with BoeingPhantom Works, the electronic eye is capable of 360 degree video processing,based on bionic principles that mimic the optical movements of some insects andreptiles. Initial applications for this technology will be for the detection ofvery fast moving targets such as missile interceptors, deployment of fast movingground vehicles and airborne platforms like unmanned aerial vehicles. Beyond these products other opportunities exist for ViaLogy's technology asannounced during the year. A technical breakthrough to improve the stability andperformance of miniature vibratory gyroscopes, achieved in collaboration withNASA's Jet Propulsion Laboratory and Boeing, which has wider applications in theemerging Micro Electro-Mechanical Systems (MEMS) market; the development of thedual-beam Reverse Photo-Acoustic Spectrometer (REPAS) with the Oak RidgeNational Laboratory for the detection of chemical, biological, radiological,nuclear and explosive materials; and, selection by the US Department of Defenseto provide a command and control platform for joint experiments to support thenext generation Joint Force Protection Advanced Security (JFPASS). An investment is being made to establish a strong sales and marketing team inorder for the Company to be able to exploit the opportunities available to it bybuilding relationships with potential partners and identifying global saleschannels. As you can see it is an exciting time for ViaLogy and the Board is enthusiasticand confident about the progress the Company will make over the next year andbeyond." End For further information please contact: ViaLogyTerry Bond, Chairman +44 (0)1235 834734 or 07860 842756Seymour Pierce Mark Percy, Nominated Adviser +44 (0)20 7107 8000Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.